Owens & Minor, Inc.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, MCK has a market cap of 86.11B. Regarding current trading prices, OMI is priced at $7.16, while MCK trades at $687.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas MCK's P/E ratio is 31.49. In terms of profitability, OMI's ROE is -0.45%, compared to MCK's ROE of -1.15%. Regarding short-term risk, OMI is more volatile compared to MCK. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, COR has a market cap of 53.96B. Regarding current trading prices, OMI is priced at $7.16, while COR trades at $278.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas COR's P/E ratio is 32.18. In terms of profitability, OMI's ROE is -0.45%, compared to COR's ROE of +1.85%. Regarding short-term risk, OMI is more volatile compared to COR. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, ABC has a market cap of 36.15B. Regarding current trading prices, OMI is priced at $7.16, while ABC trades at $179.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas ABC's P/E ratio is 21.92. In terms of profitability, OMI's ROE is -0.45%, compared to ABC's ROE of +1.72%. Regarding short-term risk, OMI is more volatile compared to ABC. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, CAH has a market cap of 35.47B. Regarding current trading prices, OMI is priced at $7.16, while CAH trades at $148.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas CAH's P/E ratio is 23.29. In terms of profitability, OMI's ROE is -0.45%, compared to CAH's ROE of -0.50%. Regarding short-term risk, OMI is more volatile compared to CAH. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, HSIC has a market cap of 8.58B. Regarding current trading prices, OMI is priced at $7.16, while HSIC trades at $70.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas HSIC's P/E ratio is 21.95. In terms of profitability, OMI's ROE is -0.45%, compared to HSIC's ROE of +0.11%. Regarding short-term risk, OMI is more volatile compared to HSIC. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, PBH has a market cap of 4.36B. Regarding current trading prices, OMI is priced at $7.16, while PBH trades at $88.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas PBH's P/E ratio is 20.68. In terms of profitability, OMI's ROE is -0.45%, compared to PBH's ROE of +0.12%. Regarding short-term risk, OMI is more volatile compared to PBH. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, PDCO has a market cap of 2.77B. Regarding current trading prices, OMI is priced at $7.16, while PDCO trades at $31.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas PDCO's P/E ratio is 20.48. In terms of profitability, OMI's ROE is -0.45%, compared to PDCO's ROE of +0.14%. Regarding short-term risk, OMI is more volatile compared to PDCO. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, GRDN has a market cap of 1.63B. Regarding current trading prices, OMI is priced at $7.16, while GRDN trades at $25.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas GRDN's P/E ratio is -14.58. In terms of profitability, OMI's ROE is -0.45%, compared to GRDN's ROE of -1.16%. Regarding short-term risk, OMI is more volatile compared to GRDN. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, WGRX has a market cap of 132.98M. Regarding current trading prices, OMI is priced at $7.16, while WGRX trades at $2.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas WGRX's P/E ratio is -17.07. In terms of profitability, OMI's ROE is -0.45%, compared to WGRX's ROE of -1.74%. Regarding short-term risk, OMI is less volatile compared to WGRX. This indicates potentially lower risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, ZYXI has a market cap of 65.01M. Regarding current trading prices, OMI is priced at $7.16, while ZYXI trades at $2.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas ZYXI's P/E ratio is -8.96. In terms of profitability, OMI's ROE is -0.45%, compared to ZYXI's ROE of -0.24%. Regarding short-term risk, OMI is more volatile compared to ZYXI. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, GEG has a market cap of 53.60M. Regarding current trading prices, OMI is priced at $7.16, while GEG trades at $1.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas GEG's P/E ratio is -191.82. In terms of profitability, OMI's ROE is -0.45%, compared to GEG's ROE of +0.00%. Regarding short-term risk, OMI is more volatile compared to GEG. This indicates potentially higher risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, HX has a market cap of 53.37M. Regarding current trading prices, OMI is priced at $7.16, while HX trades at $2.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas HX's P/E ratio is -1.84. In terms of profitability, OMI's ROE is -0.45%, compared to HX's ROE of -0.04%. Regarding short-term risk, OMI is less volatile compared to HX. This indicates potentially lower risk in terms of short-term price fluctuations for OMI.

OMI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, OMI stands at 548.56M. In comparison, RDGT has a market cap of 6.26M. Regarding current trading prices, OMI is priced at $7.16, while RDGT trades at $1.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

OMI currently has a P/E ratio of -1.51, whereas RDGT's P/E ratio is -0.32. In terms of profitability, OMI's ROE is -0.45%, compared to RDGT's ROE of N/A. Regarding short-term risk, OMI is less volatile compared to RDGT. This indicates potentially lower risk in terms of short-term price fluctuations for OMI.